华法林剂量指南。

J Zatuchni
{"title":"华法林剂量指南。","authors":"J Zatuchni","doi":"10.1177/106002808802201022","DOIUrl":null,"url":null,"abstract":"are suggested. 10 The suggestions are empirical and are to be modified depending on desired goals and response of the patient. A PT of 14-15 sec corresponds approximately to a PT ratio of 1.21.5, and a PT of 18-20 sec to a PT ratio of 1.5-2.0. In turn, any PT ratio can be converted to the respective INR value obtained from Table I and adjustments made in the dose of warfarin if necessary. In such a manner, important variability in the PT ratio caused by different brands and batches of thromboplastin and instruments may be accounted for; also, the INR scale will facilitate the process of determinating optimal therapeutic ranges.\",12 Finally, it is also important to note that PT is timeand temperature-dependent. Spurious shortening may occur when blood is in contact with glass surfaces for longer than one hour and may lead to unnecessarily larger doses of warfarin.\" Also, potential complications may occur if different preparations of warfarin are employed. I' The warfarin doses suggested above are based on daily results of prothrombin time for inpatients. For outpatients, a reasonable determination is possible based on analysis of dose employed and response, with PT obtained at frequent intervals initially and at longer intervals later, preferably every 3 weeks and perhaps as long as every 12 weeks.\" 10.0 7.5 5.0 2.5 o WARFARIN DOSE (rng)","PeriodicalId":77709,"journal":{"name":"Drug intelligence & clinical pharmacy","volume":"22 10","pages":"825-6"},"PeriodicalIF":0.0000,"publicationDate":"1988-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/106002808802201022","citationCount":"0","resultStr":"{\"title\":\"Guidelines for warfarin dosage.\",\"authors\":\"J Zatuchni\",\"doi\":\"10.1177/106002808802201022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"are suggested. 10 The suggestions are empirical and are to be modified depending on desired goals and response of the patient. A PT of 14-15 sec corresponds approximately to a PT ratio of 1.21.5, and a PT of 18-20 sec to a PT ratio of 1.5-2.0. In turn, any PT ratio can be converted to the respective INR value obtained from Table I and adjustments made in the dose of warfarin if necessary. In such a manner, important variability in the PT ratio caused by different brands and batches of thromboplastin and instruments may be accounted for; also, the INR scale will facilitate the process of determinating optimal therapeutic ranges.\\\",12 Finally, it is also important to note that PT is timeand temperature-dependent. Spurious shortening may occur when blood is in contact with glass surfaces for longer than one hour and may lead to unnecessarily larger doses of warfarin.\\\" Also, potential complications may occur if different preparations of warfarin are employed. I' The warfarin doses suggested above are based on daily results of prothrombin time for inpatients. For outpatients, a reasonable determination is possible based on analysis of dose employed and response, with PT obtained at frequent intervals initially and at longer intervals later, preferably every 3 weeks and perhaps as long as every 12 weeks.\\\" 10.0 7.5 5.0 2.5 o WARFARIN DOSE (rng)\",\"PeriodicalId\":77709,\"journal\":{\"name\":\"Drug intelligence & clinical pharmacy\",\"volume\":\"22 10\",\"pages\":\"825-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1988-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/106002808802201022\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug intelligence & clinical pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/106002808802201022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug intelligence & clinical pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/106002808802201022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Guidelines for warfarin dosage.
are suggested. 10 The suggestions are empirical and are to be modified depending on desired goals and response of the patient. A PT of 14-15 sec corresponds approximately to a PT ratio of 1.21.5, and a PT of 18-20 sec to a PT ratio of 1.5-2.0. In turn, any PT ratio can be converted to the respective INR value obtained from Table I and adjustments made in the dose of warfarin if necessary. In such a manner, important variability in the PT ratio caused by different brands and batches of thromboplastin and instruments may be accounted for; also, the INR scale will facilitate the process of determinating optimal therapeutic ranges.",12 Finally, it is also important to note that PT is timeand temperature-dependent. Spurious shortening may occur when blood is in contact with glass surfaces for longer than one hour and may lead to unnecessarily larger doses of warfarin." Also, potential complications may occur if different preparations of warfarin are employed. I' The warfarin doses suggested above are based on daily results of prothrombin time for inpatients. For outpatients, a reasonable determination is possible based on analysis of dose employed and response, with PT obtained at frequent intervals initially and at longer intervals later, preferably every 3 weeks and perhaps as long as every 12 weeks." 10.0 7.5 5.0 2.5 o WARFARIN DOSE (rng)
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信